Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Axsome Therapeutics, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AXSM
Nasdaq
2830
www.axsome.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Axsome Therapeutics, Inc.
Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation
- Aug 31st, 2026 5:00 am
Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
- Aug 29th, 2026 10:05 am
Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run
- Aug 23rd, 2026 3:20 pm
Axsome's Q2 Earnings Meet Estimates, Auvelity Drives Y/Y Revenues
- Aug 11th, 2026 12:16 pm
Axsome Therapeutics (AXSM) Shares Just Climbed, So What Is Driving Attention Now?
- Aug 11th, 2026 11:11 am
Does Axsome Therapeutics (AXSM) Look Fairly Valued At This Price?
- Aug 11th, 2026 5:10 am
AXSM Stock Advances On CEO’s Pipeline Claim: One New Drug Filing Yearly Through 2030
- Aug 10th, 2026 12:51 pm
Axsome Therapeutics shares gain 2% as strong sales growth offsets Q2 miss
- Aug 10th, 2026 8:11 am
Axsome (AXSM) Reports Q2 Earnings: What Key Metrics Have to Say
- Aug 10th, 2026 7:30 am
Axsome Therapeutics Q2 Earnings Call Highlights
- Aug 10th, 2026 7:03 am
Axsome Therapeutics (AXSM) Reports Q2 Loss, Misses Revenue Estimates
- Aug 10th, 2026 6:30 am
The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight
- Aug 6th, 2026 8:31 am
Alpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
- Aug 6th, 2026 8:00 am
Countdown to Axsome (AXSM) Q2 Earnings: Wall Street Forecasts for Key Metrics
- Aug 5th, 2026 7:15 am
Gilead Sciences (GILD) Reports Q2 Loss, Beats Revenue Estimates
- Aug 4th, 2026 3:15 pm
Prediction: These 2 Stocks Will Keep Winning No Matter What the Market Does
- Aug 4th, 2026 1:20 pm
Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for
- Aug 3rd, 2026 8:00 am
New Strong Sell Stocks for July 31st
- Jul 31st, 2026 2:48 am
Axsome Therapeutics (AXSM) Stock is Attractive on the Back of its Key Drug
- Jul 24th, 2026 8:06 am
Scroll